Price (delayed)
$1.315
Market cap
$135.46M
P/E Ratio
131.5
Dividend/share
N/A
EPS
$0.01
Enterprise value
$269.59M
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation
There are no recent dividends present for ARAY.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.